Clinical trial
A Comparative Study on the Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy
NCT00272467 is registered in ClinicalTrials.gov with Korea Otsuka International Asia Arab as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparative Study on the Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy
- Lead sponsor
- Korea Otsuka International Asia Arab
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- April 30, 2008
- Enrollment
- 132 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.